{
    "2020-04-30": [
        [
            {
                "time": "",
                "orginal_text": "被高瓴看好医药外包行业 具备诞生世界龙头的潜力（附股）",
                "features": {
                    "keywords": [
                        "高瓴",
                        "医药外包",
                        "世界龙头",
                        "潜力"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "外包行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "国际药企受疫情影响暂缓研发计划 国内CRO公司复工复产或迎发展良机",
                "features": {
                    "keywords": [
                        "疫情",
                        "国际药企",
                        "研发计划",
                        "CRO公司",
                        "复工复产",
                        "发展良机"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "CRO公司"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "【粤开策略】两股连续十日获外资增持",
                "features": {
                    "keywords": [
                        "粤开策略",
                        "外资",
                        "增持"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "QFII一季度青睐白马股，重仓银行医药电子",
                "features": {
                    "keywords": [
                        "QFII",
                        "一季度",
                        "白马股",
                        "重仓",
                        "银行",
                        "医药",
                        "电子"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "银行",
                        "医药",
                        "电子"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "三维工程“双方案”8.48亿元收购诺奥化工 盈科资本参与战略投资",
                "features": {
                    "keywords": [
                        "三维工程",
                        "双方案",
                        "收购",
                        "诺奥化工",
                        "盈科资本",
                        "战略投资"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "化工"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "【光大医药|Q1点评】泰格医药：业绩仍实现增长，H股上市有望加速国际化",
                "features": {
                    "keywords": [
                        "光大医药",
                        "Q1点评",
                        "泰格医药",
                        "业绩增长",
                        "H股上市",
                        "国际化"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}